Entity Common Stock, Shares Outstanding of Evofem Biosciences, Inc. from 30 Apr 2015 to 09 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Evofem Biosciences, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Apr 2015 to 09 Mar 2026.
  • Evofem Biosciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 09 Mar 2026 was 132,530,081, a 17% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Evofem Biosciences, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 132,530,081 +19,173,727 +17% 09 Mar 2026 10-K 11 Mar 2026 2025 FY
Q3 2025 126,685,925 +26,357,239 +26% 12 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 118,656,354 +18,327,668 +18% 09 Aug 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 113,356,354 +67,416,845 +147% 27 Mar 2025 10-K/A 28 Mar 2025 2024 FY
Q3 2024 100,328,686 +89,598,476 +835% 08 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 100,328,686 +98,019,667 +4245% 08 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 45,939,509 -170,021,837 -79% 21 Mar 2024 10-K 27 Mar 2024 2023 FY
Q3 2023 10,730,210 09 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 2,309,019 -83,150,195 -97% 09 Jun 2023 10-Q 16 Jun 2023 2023 Q1
Q1 2023 215,961,346 +48,178,337 +29% 07 Apr 2023 10-K 27 Apr 2023 2022 FY
Q4 2022 121,222,615 16 Dec 2022 10-Q 06 Jan 2023 2022 Q3
Q2 2022 85,459,214 -69,749,242 -45% 09 Aug 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 167,783,009 +64,947,335 +63% 28 Feb 2022 10-K 10 Mar 2022 2021 FY
Q3 2021 163,144,964 +81,864,678 +101% 31 Oct 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 155,208,456 +73,928,170 +91% 31 Jul 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 102,835,674 +53,113,006 +107% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 81,280,286 +34,469,483 +74% 31 Oct 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 81,280,286 +34,679,228 +74% 31 Jul 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 49,722,668 +14,355,477 +41% 30 Apr 2020 10-Q 06 May 2020 2020 Q1
Q3 2019 46,810,803 +20,943,555 +81% 31 Oct 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 46,601,058 +20,796,433 +81% 31 Jul 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 35,367,191 +17,603,851 +99% 30 Apr 2019 10-Q 07 May 2019 2019 Q1
Q3 2018 25,867,248 +12,016,647 +87% 31 Oct 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 25,804,625 +11,972,878 +87% 30 Jul 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 17,763,340 +3,931,593 +28% 30 Apr 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 17,763,340 09 Feb 2018 10-K 26 Feb 2018 2017 FY
Q3 2017 13,850,601 +22,105 +0.16% 01 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 13,831,747 +16,158 +0.12% 01 Aug 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 13,831,747 +32,551 +0.24% 28 Apr 2017 10-Q 11 May 2017 2017 Q1
Q3 2016 13,828,496 +98,086 +0.71% 01 Nov 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 13,815,589 +112,679 +0.82% 01 Aug 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 13,799,196 +127,885 +0.94% 29 Apr 2016 10-Q 12 May 2016 2016 Q1
Q3 2015 13,730,410 31 Oct 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 13,702,910 31 Jul 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 13,671,311 30 Apr 2015 10-Q 14 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.